Preview

Роль тонкоигольной аспирационной биопсии в динамическом наблюдении пациентов с узловым зобом

https://doi.org/10.14341/ket20128330-43

Полный текст:

Аннотация

Обзор литературы посвящен применению тонкоигольной аспирационной биопсии (ТАБ) в диагностике узловых образований щитовидной железы. Использование новой классификационной системы интерпретации результатов ТАБ позволяет значительно увеличить воспроизводимость данного метода и существенно сократить число ложноотрицательных результатов. Представлены современные данные об эпидемиологии узловых образований, новой системе интерпретации цитологических заключений ТАБ, проведена оценка роли ТАБ в динамическом наблюдении доброкачественных образований щитовидной железы.

Об авторах

G Semkina

аспирант ФГБУ Эндокринологический научный центр


V Smirnova

аспирант кафедры эндокринологии Первого МГМУ им. И.М. Сеченова


F Abdulhabirova

канд. мед. наук, ведущий научный сотрудник отделения терапии с группой патологии метаболизма и ожирения ФГБУ Эндокринологический научный центр


V Vanushko

доктор мед. наук, главный научный сотрудник отдела хирургии эндокринных органов ФГБУ Эндокринологический научный центр


Список литературы

1. Баженова Е.А. Оптимизация диагностики раков щитовидной железы 10 мм в наибольшем измерении: Автореф. дис. … канд. мед. наук. Барнаул, 2004.

2. Белобородов В.А., Олифирова О.С., Шевченко С.П. и др. Морфологическая верификация рака щитовидной железы. Сиб. онкол. журн. 2007; 2: 70–72.

3. Ванушко В.Э., Кузнецов Н.С., Бельцевич Д.Г. и др. Прицельная тонкоигольная пункционная биопсия в диагностике рака щитовидной железы. Хирургия 2003; 10: 67–72.

4. Ванушко В.Э., Кузнецов Н.С., Гарбузов П.И., Фадеев В.В. Рак щитовидной железы. Пробл. эндокринол. 2005; 4: 43–53.

5. Гринева Е.Н. Роль тонкоигольной аспирационной биопсии в диагностике узловых образований щитовидной железы. Пробл. эндокринол. 2005; 1: 10–15.

6. Дедов И.И. Клинические рекомендации Российской ассоциации эндокринологов по диагностике и лечению узлового зоба: Матер. 3-го Всерос. тиреоидологич. конгр. М., 2004; 5—12.

7. Дедов И.И., Мельниченко Г.А., Фадеев В.В. и др. Клинические рекомендации Российской ассоциации эндокринологов по диагностике и лечению узлового зоба. Пробл. эндокринол. 2005; 5: 40–42.

8. Дедов И.И., Кузнецов Н.С., Мельниченко Г.А. и др. Эндокринная хирургия: “узкая” специальность или насущная необходимость? Клин. и экспер. тиреоидол. 2008; 1: 8–12.

9. Зайратьянц О.В. Эпидемиология и этиологическая структура узлового зоба по данным аутопсий. Актуальные проблемы за- болеваний щитовидной железы: Матер. 2-го Всерос. тиреои- дологич. конгр. М., 2002; 50–60.

10. Зубеев П.С., Потехина Ю.П., Коновалов В.А. Расширение воз- можностей тонкоигольной аспирационной биопсии под кон- тролем УЗИвдиагностике узловых образований щитовидной железы . Клин. тиреоидол. 2004; 3: 15–18.

11. Иванов Ю.В., Панченков Д.Н., Соловьев Н.А. и др. Роль пунк- ционной тонкоигольной аспирационной биопсии в диагнос- тике узловых образований щитовидной железы. Эндоскопич. хир. 2010; 3: 25–34.

12. Коренев С.В., Плешков В.Г., Тугай В.В. Особенности доопера- ционной диагностики рака щитовидной железы. Рос. мед. журн. 2005; 3: 13–16.

13. Митьков В.В. Практическое руководство по ультразвуковой диагностике. М: Видар, 2006.

14. Непомнящая Е.М., Бирина Л.М., Рубцов В.Р. и др. Клинико- морфологические критерии прогноза рака щитовидной же- лезы. Естественные науки 2004; 2: 95–97.

15. Орлинская Н.Ю., Саранцев Б.В. Особенности морфологичес- кой диагностики заболеваний щитовидной железы. Меди- цинский альманах 2011; 32: 172–174.

16. Тимофеева Н.И., Черников Р.И., Слепцов И.В. и др. Диагности- ческая ценность тонкоигольной аспирационной биопсии уз- лов щитовидной железы. Вестн. Санкт-Петербургского уни- верситета 2006; 11: 79–85.

17. Толстокоров А.С., Ершова Г.И., Коваленко Ю.В., Дергунова С.А. Пункционные методы диагностики и лечения заболеваний щитовидной железы. Саратовский науч.-мед. журн. 2010; 2: 464–467.

18. Фадеев В.В., Ванушко В.Э. Комментарии к клиническим рекомендациям Американской ассоциации клинических эндокринологов и Европейской тиреоидологической ассоциации по узловому зобу 2010 года . Клин. и экспер. тиреоидол. 2010; 3: 6–16.

19. Федотов Ю.Н., Воробьев С.Л., Черников Р.А. и др. Тонкоиголь- ная аспирационная биопсия в диагностике заболеваний щи- товидной железы. Корреляция между заключением цитолога и гистолога, технические аспекты . Клин. и экспер. тиреои- дол. 2009; 4: 28–33.

20. AACE/AME/ETA Thyroid Nodule Guidelines. Endocr. Pract. 2010; 16: 1–43.

21. Abdul-Jaber H.B., Lynn J. The surgical management of thyroid cancer. Nucl. Med. Commun. 2004; 25: 869–872.

22. Abele J.S., Levine R.A. Diagnostic criteria and risk-adapted approach to indeterminate thyroid cytodiagnosis. Cancer Cyto- pathol. 2010; 118: 415–422.

23. Ali S.Z., Cibas E.S. The Bethesda System for Reporting Thyroid Cytopathology: Definitions, Criteria and Explanatory Notes . New York, Springer, 2009.

24. American Association of Clinical Endocrinologists and Associa- zione Medici Endocrinologi medical guidelines for clinical prac- tice for the diagnosis and management of thyroid nodules. Endocr. Pract. 2006; 12: 63–103.

25. Baloch Z.W., Fleisher S., LiVolsi V.A. et al. Diagnosis of “follicular neoplasm”: a gray zone in thyroid fine-needle aspiration cytology. Diagn. Cytopathol. 2002; 26: 41–44.

26. Baloch Z.W., Livolsi V.A., Asa S.L. et al. Diagnostic terminology and morphological criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute thyroid fine- needle aspiration state of the science conference. Diagn. Cytopathol. 2008; 36: 425–433.

27. Bartolazzi A., Gasbarri A., Papotti M. et al. The Thyroid Cancer Study Group. Application of a immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Lancet 2001; 357: 1644–1650.

28. Belfiore A., La Rosa G.L. Fine-needle aspiration biopsy of the thy- roid . J. Endocrin. Met. Clin. North. Am. 2001; 30: 361–400.

29. Bishop-Pitman M., Abele J., Ali S.Z. et al. Techniques for thyroid FNA: a synopsis of the National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference. Diagn. Cytopahol. 2008; 6: 407–424.

30. Boelaert K., Horacek J., Holder R.L. et al. Serum Thyrotropin Concentration as a Novel Predictor of Malignancy in Thyroid Nodules Investigated by Fine-Needle Aspiration. J. Clin. Endocrinol. Met. 2006; 91: 4295–4301.

31. British Thyroid Association, Royal College of Physicians: British Thyroid Association Guidelines for the management of thyroid cancer. 2nd edition. 2007 http:www.british-thyroid- association.org/Guidelines/

32. Caraci P., Aversa S., Mussa A. et al. Role of fineneedle aspiration biopsy and frozen-section evaluation in the surgical management of thyroid nodules. Br. J. Surg. 2002; 89: 797–701.

33. Cesur M., Corapcioglu D., Bulut S. et al. Comparison of palpation- guided fine-needle aspiration biopsy to ultrasound-guided fine- needle aspiration biopsy in the evaluation of thyroid nodules. Thyroid 2006; 16; 555–561.

34. Chehade J.M., Silverberg A.B., Kim J. et al. Role of repeated fine- needle aspiration of thyroid nodules with benign cytologic features. Endocr. Pract. 2001; 7: 237–243.

35. hudova D., Wilde J.I., Wang E.T. et al. Molecular classification of thyroid nodules using high-dimensionality genomic data. J. Clin. Endocrin. Metab. 2010; 95: 5296–5304.

36. Cibas E.S., Alexander E.K., Benson C.B. et al. Indications for Thyroid FNA and Pre-FNA Requirements: A Synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn. Cytopathol. 2008; 36: 390–399.

37. Cibas E.S., Ali S.Z. The Bethesda System for Reporting Thyroid Cytopathology. Am. J. Clin. Pathol. 2009; 132: 658–665.

38. Cibas E.S., Bibbo M. Thyroid FNA: Challenges and Opportunities. Acta Cytologica 2011; 55: 489–491.

39. Cooper D.S., Doherty G.M., Haugen B.R. et al. Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer. The American Thyroid Association Guidelines Taskforce. Thyroid 2006; 16: 1–33.

40. Cramer H. Fine needle aspiration cytology of the thyroid: an appraisal. Cancer Cytopathol. 2000; 90: 325–329.

41. Davidov T., Trooskin S.Z. et al. Routine second-opinion cytopathology review of thyroid fine needle aspiration biopsies reduces diagnostic thyroidectomy. Surgery 2010; 148: 1294–1301.

42. Deveci M.S., Deveci G., LiVolsi V.A. et al. Fine-needle aspiration of follicular lesions of the thyroid: diagnosis and follow-up. Cyto- journal 2006; 3: 9.

43. Duek S.D., Goldenberg D., Linn S. et al. The role of fineneedle aspi- ration and intraoperative frozen section in the surgical manage- ment of solitary thyroid nodules. Surg. Today 2002; 32: 857–861.

44. Eedes C.R., Wang H.H. Cost-effectiveness of immediate specimen adequacy assessment of thyroid fine-needle aspirations. Am. J. Clin. Pathol. 2004; 121: 64–69.

45. Eng C.Y., Quraishi M.S., Bradley P.J. Meviaewnagement of Thyroid nodules in adult patients. Head & Neck Oncology 2010; 2: 11–16.

46. Faquin W.C., Baloch Z.W. Fine-needle aspiration of follicular pat- terned lesions of the thyroid: diagnosis, management, and followup according to National Cancer Institute [NCI] recommenda- tions. Diagn. Cytopathol. 2010; 38: 731–739.

47. Filie A.C., Asa S.L., Geisinger K.R. et al. Utilization of ancillary studies in thyroid fine needle aspirates: a synopsis of the National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference. Diagn. Cytopathol. 2008; 36: 438–441.

48. Flanagan M.B. et al. Repeat Thyroid Nodule Fine-Needle Aspi- ration in Patients With Initial Benign Cytologic Results. Am. J. Clin. Pathol. 2006; 125 (5): 698—702.

49. Frates M.C., Benson C.B., Charboneau J.W. et al. Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement. Radiology 2005; 237: 794–800.

50. Fusco A., Chiapetta G., Hui P. et al. Assessment of RET/PTC onco- gene activation and clonality in thyroid nodules with incomplete morphological evidence of papillary carcinoma. Am. J. Pathol. 2002; 160: 2157–2167.

51. French C.A., Alexander E.K., Cibas E.S. et al. Genetic and biologi- cal subgroups of low-stage follicular thyroid cancer. Am. J. Pathol. 2003; 162: 1053–1060.

52. Gabalec F., Cap J., Ryska A. et al. Benign fine-needle aspiration cytology of thyroid nodule: to repeat or not to repeat? Eur. J. Endocrinol. 2009; 161: 933–937.

53. Gharib H., Papini E. Thyroid nodules: Clinical importance, assess- ment, and treatment. Endocrin. Met. Clin. N. Am. 2007; 36: 707–735.

54. Giorgadze T., Rossi E.D., Fadda G. et al. Does the fine-needle aspi- ration diagnosis of “Hürthle-cell neoplasm/follicular neoplasm with oncocytic features” denote increased risk of malignancy? Diagn. Cytopathol. 2004; 31: 307–312.

55. Haymart M.R., Repplinger D.J., Leverson G.E. et al. Higher Serum Thyroid Stimulating Hormone Level in Thyroid Nodule Patients Is Associated with Greater Risks of Differentiated Thyroid Cancer and Advanced Tumor Stage. J. Clin. Endocrinol. Met. 2008; 93: 809–814.

56. Jo V.Y., Stelow E.B., Dustin S.M., Hanley K.Z. Malignancy risk for fine-needle aspiration of thyroid lesions according to the Bethesda System for Reporting Thyroid Cytopathology. Am. J. Clin. Pathol. 2010; 134: 450–456.

57. Jo V.Y., Van der Laan P.A., Marqusee E., Krane J.F. Repeatedly Nondiagnostic Thyroid Fine-Needle Aspirations Do Not Modify Malignancy Risk. Acta Cytologica 2011; 55: 539–543.

58. Izquierdo R., Arekat M.R., Knudson P.E. et al. Comparison of pal- pation-guided versus ultrasound-guided fine-needle aspiration biopsies of thyroid nodules in an outpatient endocrinology prac- tice. Endocr. Pract. 2006; 12: 609–614.

59. Kelly N.P., Lim J.C., DeJong S. et al. Specimen adequacy and diag- nostic specificity of ultrasound-guided fine needle aspirations of nonpalpable thyroid nodules. Diagn. Cytopathol. 2006; 34: 188–190.

60. Khan I., Naz S., Akhter Z.M., Aziz N. Diagnostic accuracy of fine needle aspiration of thyroid nodule versus biopsy in thyroid lesions. J. Ayub. Med. Coll. Abbottabad. 2010; 22: 179–182.

61. Kim E.-K., Park C.S., Chung W.Y. New et al. Sonographic Criteria for Recommending Fine-Needle Aspiration Biopsy of Non- palpable Solid Nodules of the Thyroid. Am. J. Roentgenol. 2002; 178: 687–691.

62. Kocjan G., Cochand-Priollet B., de Agustin P.P. et al. Diagnostic terminology for reporting thyroid fine needle aspiration cytology: European Federation of Cytology Societies thyroid working party symposium, Lisbon 2009. Cytopathology 2010; 21: 86–92.

63. Koen T.M., Mody D.R., Scheiber-Pacht M. et al. Limiting the use of atypical/inconclusive as a category in nongynecologic cytology specimens. Arch. Pathol. Lab. Med. 2010; 134: 1016–1019.

64. Layfield L.J., Abrams J., Cochand-Priollet B. et al. Post-thyroid FNA testing and treatment options: a synopsis of the national cancer institute thyroid fine needle aspiration state of the science con- ference. Diagn. Cytopathol. 2008; 36: 442–448.

65. Layfield L.J., Morton M.J., Cramer H.M., Hirschowitz S. Implications of the proposed thyroid fine-needle aspiration category of ‘follicular lesion of undetermined significance’: a five-year multi- institutional analysis. Diagn. Cytopathol. 2009; 37: 710–714.

66. Layfield L.J., Cibas E.S., Baloch Z. Thyroid fine needle aspiration cytology: a review of the National Cancer Institute state of the science symposium. Cytopathology 2010; 21: 75–85.

67. Lee Y.H., Kim D.W., In H.S. et al. Differentiation between Benign and Malignant Solid Thyroid Nodules Using an US Classification System. Korean J. Radiol. 2011; 12: 559–567.

68. Ljung E.B., Langer J., Mazzaferri E.L. et al. Training, credentialing and re-credentialing for the performance of a thyroid FNA: a synopsis of the National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference. Diagn. Cytopathol. 2008; 36: 400–406.

69. Luu M.H., Fischer A.H., Pisharodi L., Owens C.L. Improved preoperative definitive diagnosis of papillary thyroid carcinoma in FNAs prepared with both ThinPrep and conventional smears com- pared with FNAs prepared with ThinPrep alone. Cancer Cytopathol. 2011; 119: 68–73.

70. Luu M.H., Fischer A.H., Stockl T.J. et al. Atypical Follicular Cells with Equivocal Features of Papillary Thyroid Carcinoma Is Not a Low-Risk Cytologic Diagnosis. Acta Cytologica 2011; 55: 526–530.

71. Marchevsky A.M., Walts A.E., Bose S. et al. Evidence-based evaluation of the risks of malignancy predicted by thyroid fine-needle aspiration biopsies. Diagn. Cytopathol. 2010; 38: 252–259.

72. Melillo R.M., Santoro M., Vecchio G. Differential diagnosis of thyroid nodules using fineneedle aspiration cytology and oncogene mutation screening: are we ready? F1000 Med. Rep. 2010; 2: 62.

73. Merchant S.H., Izquierdo R., Khurana K.K. Is repeated fine-needle aspiration cytology useful in the management of patients with benign nodular thyroid disease? Thyroid 2000; 10: 489–492.

74. Miccoli P., Minuto M.N., Galleri D. et al. Incidental thyroid carcinoma in a large series of consecutive patients operated on for benign thyroid disease. ANZ J. Surg. 2006; 76: 123–126.

75. Moon W.-J., Baek J.H., Jung S.L. et al. Ultrasonography and the Ultrasound-Based Management of Thyroid Nodules: Consensus Statement and Recommendations. Korean J. Radiol. 2011; 12: 1–14.

76. Nasuti J.F., Gupta P.K., Baloch Z.W. Diagnostic value and cost effectiveness of on site evaluation of fine needle aspiration specimens. Review of 5,688 cases. Diagn. Cytopathol. 2002; 27: 1–4.

77. Nayar R., Ivanovic M. The indeterminate thyroid fine-needle aspi- ration: experience from an academic center using terminology similar to that proposed in the 2007 National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference. Cancer Cytopathol. 2009; 117: 195–202.

78. NCI Thyroid Fine Needle Aspiration State of Science Conference. Diagn. Cytopathol. 2008; 6: 388–448.

79. Ohori N.P., Nikiforova M.N., Schoedel K.E. et al. Contribution of molecular testing to thyroid fine-needle aspiration cytology of ‘follicular lesion of undetermined significance/atypia of undetermined significance’. Cancer Cytopathol. 2010; 118: 17–23.

80. Ohori N.P., Schoedel K.E. Variability in the Atypia of Undeter- mined Significance/Follicular Lesion of Undetermined Significance Diagnosis in the Bethesda System for Reporting Thyroid Cytopathology: Sources and Recommendations. Acta Cytologica 2011; 55: 492–498.

81. Olson M.T., Clark D.P., Erozan Y.S., Ali S.Z. Spectrum of Risk of Malignancy in Subcategories of ‘Atypia of Undetermined Significance’. Acta Cytologica 2011; 5: 518–525.

82. Ono J.C., Wilbur D.C., Lee H. et al. Cytologic Features of Focal Papillary Thyroid Carcinoma Arising within Follicular Adenoma: A Masked Cytomorphologic Analysis of 17 Cases. Acta Cytologica 2011; 55: 531–538.

83. Orlandi A., Puscar A., Capriata E., Fideleff H. Repeated Fine-Needle Aspiration of the Thyroid in Benign Nodular Thyroid Disease: Critical Evaluation of Long-Term Follow-Up. Thyroid 2005; 15: 274–281.

84. Pu R.T., Yang J., Wasserman P.G. et al. Does Hurthle cell lesion/ neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration? Diagn. Cytopathol. 2006; 34: 330–334.

85. Redman R., Yoder B.J., Massoll N.A. Perceptions of diagnostic terminology and cytopathologic reporting of fineneedle aspiration biopsies of thyroid nodules: a survey of clinicians and pathologists. Thyroid 2006; 16: 1003–1008.

86. Reiners C., Wegscheider K., Schicha H. et al. Prevalence of thyroid disorders in the working population of Germany: ultrasonography screening in 96,278 unselected employees. Thyroid 2004; 14: 926–932.

87. Renshaw A.A. Should ‘atypical follicular cells’ in thyroid fine-needle aspirates be subclassified? Cancer Cytopathol. 2010; 118: 186–189.

88. Renshaw A.A. Significance of repeatedly nondiagnostic thyroid fine-needle aspirations. Am. J. Clin. Pathol. 2011; 135: 750–752.

89. Richards M.L., Bohnenblust E., Sirinek K., Bingener J. Nondiag- nostic thyroid fine-needle aspiration biopsies are no longer a dilemma. Am. J. Surg. 2008; 196: 398–402.

90. Saggiorato E., De Pompa R., Volante M., Cappia S. et al. Characterization of thyroid ‘follicular neoplasms’ in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers: a proposal for clinical application. Endocrine-Related Cancer 2005; 12: 305–317.

91. Sclabas G.M., Staerkel G.A., Shapiro S.E. et al. Fineneedle aspiration of the thyroid and correlation with histopathology in a contemporary series of 240 patients. Am. J. Surg. 2003; 186: 702–709.

92. Sebo T.J. What are the keys to successful thyroid FNA interpreta- tion? Clin. Endocrinol. 2012; 77: 13–17.

93. Seningen J.L., Nassar A., Henry M.R. Correlation of Thyroid Nodule Fine-Needle Aspiration Cytology With Corresponding

94. Histology at Mayo Clinic, 2001–2007: An Institutional Experience of 1,945 Cases . Diagn. Cytopathol. 2012; 40: E27–E32.

95. Seong N. Ultrasonography-Guided Fine-Needle Aspiration of Thyroid Incidentaloma: Correlation With Pathological Findings. Clin. Endocrinol. 2004; 60: 145–147.

96. Sharma R., Mondal A., Shankar L.R. et al. Differentiation of malignant and benign solitary thyroid nodules using 30-and 120-minute tc-99m MIBI scans. Clin. Nucl. Med. 2004; 29: 534–537.

97. Singh R.S., Wang H.H. Timing of Repeat Thyroid Fine-Needle Aspiration in the Management of Thyroid Nodules. Acta Cytologica 2011; 55: 544–548.

98. Smadi A.A., Ajarmeh K., Wreikat F. Fine-Needle Aspiration of Thyroid Nodules has high sensitivity and specificity. Rawal Med. J. 2008; 33: 221–224.

99. Somma J., Schlecht N.F., Fink D. et al. Thyroid fine needle aspiration cytology: follicular lesions and the gray zone. Acta Cytol. 2010; 54: 123–131.

100. Stephen S., Raab S. et al. Errors in Thyroid Gland Fine-Needle Aspiration. Am. J. Clin. Pathol. 2006; 125: 873–882.

101. Theoharis C.G.A., Schofield K.M., Hammers L. et al. The Bethesda Thyroid Fine-Needle Aspiration Classification System: Year 1 at an Academic Institution. Thyroid 2009; 19: 1215–1226.

102. Thyroid cancer – UK incidence statistics http://info.cancerresearchuk.org/cancerstats/types/thyroid/incidence/

103. Thyroid cancer – UK mortality statistics http://info.cancerresearchuk.org/cancerstats/types/thyroid/mortality/

104. Van der Laan P.A., Krane J.F., Cibas E.S. The Frequency of ‘Atypia of Undetermined Significance’ Interpretations for Thyroid Fine-Needle Aspirations Is Negatively Correlated with Histologically Proven Malignant Outcomes. Acta Cytologica 2011; 55: 512–517.

105. Van der Laan P.A., Marqusee E., Krane J.F. Clinical outcome for atypia of undetermined significance in thyroid fine-needle aspirations: should repeated FNA be the preferred initial approach? Am. J. Clin. Pathol. 2011; 135: 770–775.

106. Van der Laan P.A., Renshaw A.A., Krane J.F. 2012 Atypia of undetermined significance and nondiagnostic rates in the Bethesda system for reporting thyroid cytopathology are inversely related. Am. J. Clin. Pathol. 2012; 137: 462–465.

107. Vanderpump M.P.J. The epidemiology of thyroid disease. British Med. Bull. 2011; 99: 39–51.

108. Wang C., Crapo L.M. The epidemiology of thyroid disease and implication for screening . J. Endocrinol. Met. Clin. N. Am. 1997; 26: 189–218.

109. Wang H.H. Reporting thyroid fine-needle aspiration: literature review and a proposal. Diagn. Cytopathol. 2006; 34: 67–76.

110. Wang C.C., Friedman L., Kennedy G.C. et al. A large multicenter correlation study of thyroid nodule cytopathology and histopathology. Thyroid 2011; 21: 243–251.

111. Weber D., Brainard J., Chen L. Atypical epithelial cells, cannot exclude papillary carcinoma, in fine needle aspiration of the thy- roid. Acta Cytol. 2008; 52: 320–324.

112. Wienke J.R., Chong W.K., Fielding J.R. et al. Sonographic features of benign thyroid nodules: interobserver reliability and overlap with malignancy. J. Ultrasound Med. 2003; 22: 1027–1031.

113. Yang J., Schnadig V., Logrono R., Wasserman P.G. Fine-needle aspiration of thyroid nodules: a study of 4703 patients with histologic and clinical correlations. Cancer 2007; 111: 306–315.

114. Yassa L., Cibas E.S., Benson C.B. et al. Long-term assessment of a multidisciplinary approach to thyroid nodule diagnostic evaluation. Cancer 2007; 111: 508–516.

115. Yoder B.J., Redman R., Massoll N.A. Validation of a fivetier cytodiagnostic system for thyroid fine needle aspiration biopsies using cytohistologic correlation. Thyroid 2006; 16: 78.


Для цитирования:


Semkina G., Smirnova V., Abdulhabirova F., Vanushko V. Роль тонкоигольной аспирационной биопсии в динамическом наблюдении пациентов с узловым зобом. Клиническая и экспериментальная тиреоидология. 2012;8(3):30-43. https://doi.org/10.14341/ket20128330-43

For citation:


., ., ., . The role of fine-needle aspiration biopsy in the dynamic monitoring of patients with nodular goiter. Clinical and experimental thyroidology. 2012;8(3):30-43. (In Russ.) https://doi.org/10.14341/ket20128330-43

Просмотров: 9


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1995-5472 (Print)
ISSN 2310-3787 (Online)